To ensure ease of transaction and the desire to provide a more efficient customer service, the Food and Drug Administration (FDA) hereby advises the public to send specific concerns, queries, transactions and/or documents to the following email addresses:
Type of transaction / Document / Concern | Office/s Concerned |
Compliance Document, Follow-ups, Verification of Registration of Products and License of Establishments concerning Center for Food Regulation and Research | [email protected] |
Compliance Document, Follow-ups, Verification of Registration of Products and License of Establishments concerning Center Drug Regulation and Research including veterinary medicine, vaccine, and biologicals | [email protected] |
Compliance Document, Follow-ups, Verification of Registration Of Products and License of Establishments concerning Center for Cosmetics Regulation and Research including household hazard/urban substances |
[email protected] |
Compliance Document, Follow-ups, Verification of Registration of products and License of Establishments concerning Center for Device Regulation, Radiation Health and Research | [email protected] |
Qualified Persons in Industry Regulatory Affairs (QPIRA) Training, Licensing Seminar and other Seminars as spearheaded by FDA | [email protected] |
Legal related concerns/queries/follow-ups | [email protected] |
Request for meetings, courtesy calls and other related matter | [email protected] |
E-Portal Account Concerns (i.e. Requests, Change of Username, password and among others), Processes (i.e. How to Apply for FDA Certificates) | [email protected] |
All other concerns not cited this advisory are hereby requested to be sent to [email protected].
For your information and guidance.
FDA Advisory No. 2019-129